Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2

Anesthesia and Analgesia

Volumn 104, Issue 5, 2007, Pages 1179-1184

  Yang, Sufang ^a   Bhardwaj, Anish ^b   Cheng, Jian ^a   Alkayed, Nabil J ^a   Hurn, Patricia D ^a   Kirsch, Jeffrey R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYL 1 (4 PHENYLBUTYL)PIPERIDINE; GLUCOSE; GLUTAMIC ACID; OPIATE AGONIST; OPIATE ANTAGONIST; OXYGEN; PIPERIDINE DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2; RIMCAZOLE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BAX GENE; BCL 2 GENE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA DETERMINATION; GENE; GENE EXPRESSION; HYPOXIA; IMMUNOBLOTTING; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL DEATH; CELLS, CULTURED; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; NEURONS; NEUROPROTECTIVE AGENTS; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SIGMA;

EID: 34247536201     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000260267.71185.73     Document Type: Article

References (29)

1. 1-receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine affords neuroprotection from focal ischemia with prolonged reperfusion. Stroke 2000;31:976-82.
2. Takahashi H, Kirsch JR, Hashimoto K, et al. PPBP [4-phenyl-1-(4- phenylbutyl) piperidine], a potent σ-receptor ligand, decreases brain injury following transient focal ischemia in cats. Stroke 1995;26:1676-82.
3. Takahashi H, Kirsch JR, Hashimoto K, et al. PPBP[4-phenyl-1-(4- phenylbutyl)piperidine] decreases brain injury after transient focal ischemia in rats. Stroke 1996;27:2120 -3.
4. Goyagi T, Bhardwaj A, Koehler RC, et al. Potent σ1-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. Anesth Analg 2003;96:532-8.
5. Goyagi T, Goto S, Bhardwaj A, et al. Neuroprotective effect of σ(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. Stroke 2001;32:1613-20.
6. French ED, Ceci A. Non-competitive N-methyl-d-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci Lett 1990;119:159-62.
7. Lockhart BP, Soulard P, Benicourt C, et al. Distinct neuroprotective profiles for σ ligands against N-methyl-d-aspartate (NMDA), and hypoxia-mediated neurotoxicity in neuronal culture toxicity studies. Brain Res 1995;675:110-20.
8. 3H]dopamine release from rat striatal slices by Sigma receptor ligands. J Pharmacol Exp Ther 1994;271:212-9.
9. Willette RN, Lysko PG, Sauermelch CF. A comparison of (+)SK&F 10047 and MK-801 on cortical spreading depression. Brain Res 1994;648:347-51.
10. 1- receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine modulates basal and N-methyl-D-aspartate-evoked nitric oxide production in vivo. Stroke 1998;29:2404-10; discussion 2411.
11. Klette KL, DeCoster MA, Moreton JE, Tortella FC. Role of calcium in σ-mediated neuroprotection in rat primary cortical neurons. Brain Res 1995;704:31-41.
12. Xiong ZG, Zhu XM, Chu XP, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004;118:687-98.
13. Gilmore DL, Liu Y, Matsumoto RR. Review of the pharmacological and clinical profile of rimcazole. CNS Drug Rev 2004;10:1-22.
14. Beck J, Lenart B, Kintner DB, Sun D. Na-K-Cl cotransporter contributes to glutamate-mediated excitotoxicity. J Neurosci 2003;23:5061-8.
15. Araki T, Simon RP, Taki W, et al. Characterization of neuronal death induced by focally evoked limbic seizures in the C57BL/6 mouse. J Neurosci Res 2002;69:614-21.
16. Ford JM, Hanawalt PC. Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts. J Biol Chem 1997;272:28073-80.
17. Walker JM, Bowen WD, Walker FO, et al. Sigma receptors: biology and function. Pharmacol Rev 1990;42:355-402.
18. Kekuda R, Prasad PD, Fei YJ, et al. Cloning and functional expression of the human type 1 σ receptor (hσR1). Biochem Biophys Res Commun 1996;229:553-8.
19. Pan YX, Mei J, Xu J, et al. Cloning and characterization of a mouse σ1 receptor. J Neurochem 1998;70:2279-85.
20. Mei J, Pasternak GW. Molecular cloning and pharmacological characterization of the rat σ1 receptor. Biochem Pharmacol 2001;62:349-55.
21. 3H]4-phenyl-1-(4-phenylbutyl) piperidine. Synapse 1995;20:85-90.
22. Harukuni I, Bhardwaj A, Traystman RJ, et al. Neuroprotection from focal ischemia by 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is dependent on treatment duration in rats. Anesth Analg 1998;87:1299-305.
23. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989;244:1360-2.
24. Maurice T, Phan VL, Urani A, et al. Neuroactive neurosteroids as endogenous effectors for the σ1 (σ1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol 1999;81:125-55.
25. Su TP. Delineating biochemical and functional properties of σ receptors: emerging concepts. Crit Rev Neurobiol 1993;7:187-203.
26. Takahashi H, Traystman RJ, Hashimoto K, et al. Postischemic brain injury is affected stereospecifically by pentazocine in rats. Anesth Analg 1997;85:353-7.
27. Almeida S, Brett AC, Gois IN, et al. Caspase-dependent and -independent cell death induced by 3-nitropropionic acid in rat cortical neurons. J Cell Biochem 2006;98:93-101.
28. Xu L, Yenari MA, Steinberg GK, Giffard RG. Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab 2002;22:21-8.
29. Giffard RG, Swanson RA. Ischemia-induced programmed cell death in astrocytes. Glia 2005;50:299-306.